Antisense oligonucleotide delivery to cancer cell lines for the treatment of different cancer types

References

• Arnedo A, Espuelas S, Irache JM. 2002. Albumin nanoparticles for phosphodiester oligonucleotide. Int J Pharm. 244:59–72.
   PubMed Web of Science ®Google Scholar
• Baker BF, Lot SS, Condon TP, Cheng-Flournoy S, Lesnik EA, Sasmor HM, Bennett CF. 1997. 2-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J Biol Chem. 272:11994–12000.
   PubMed Web of Science ®Google Scholar
• Blanco D, Alonso MJ. 1997. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm. 43:287–294.
   Web of Science ®Google Scholar
• Cohen-Sela E, Chorny M, Koroukhov HD, Danenberg GG. 2009. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release. 133:90–95.
   PubMed Web of Science ®Google Scholar
• Davis SS, Walker IM. 1987. Multiple emulsions as targetable delivery systems. Methods Enzymol. 149:51–64.
   PubMed Web of Science ®Google Scholar
• Dilnawaz F, Singh A, Mohanty C, Sahoo SK. 2010. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials. 31:3694–3706.
   PubMed Web of Science ®Google Scholar
• Dinçer S, Türk M, Karagöz A, Uzunalan G. 2010. Potential c-myc antisense oligonucleotide carriers: PCl/PEG/PEI and PLL/PEG/PEI. Artif Cells Blood Substit Biotechnol. 39:143–154.
   PubMed Web of Science ®Google Scholar
• Donald EO, Nicholas AP. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 307:93–102.
   PubMed Web of Science ®Google Scholar
• Dubey P, Gidwani B, Pandey R, Shukla SS. 2015. In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1052466.
   PubMed Web of Science ®Google Scholar
• Erduranli H, Hazer B, Borcakli M. 2008. Post polymerization of saturated and unsaturated poly(3-hydroxy alkanoate)s. Macromol Symp. 269:161–169.
   Google Scholar
• Grage K, Jahns AC, Parlane N, Palanisamy R, Rasiah IA, Atwood JA, Rehm BH, Bernd HA. 2009. Bacterial polyhydroxyalkanoate granules: biogenesis, structure, and potential use as nano-/micro-beads in biotechnological and biomedical applications. Biomacromolecules. 10:660–669.
   PubMed Web of Science ®Google Scholar
• Hazer DB, Kilicay E, Hazer B. 2012. Poly(3-hydroxyalkanoate)s: diversification and biomedical applications: a state of the art review. Mater Sci Engineering C. 32:637–647.
   Web of Science ®Google Scholar
• Hazer B. 2010a. Amphiphilic poly(3-hydroxy alkanoate)s: potential candidates for medical applications. Energy Power Engineering. 2:1, 31–38.
   Google Scholar
• Hazer B. 2010b. Amphiphilic poly(3-hydroxy alkanoate)s: potential candidates for medical applications. Int J Polymer Sci. 2010:423460.
   PubMed Web of Science ®Google Scholar
• Kang Y, Wu J, Yin G, Huang Z, Yao Y, Liao X, et al. 2008. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Eur J Pharm Biopharm. 70:85–97.
   PubMed Web of Science ®Google Scholar
• Kilicay E, Demirbilek M, Türk M, Güven E, Hazer B, Denkbas EB. 2011. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci. 44:310–320.
   PubMed Web of Science ®Google Scholar
• Kulka M, Smith CC, Aurelian L, Fishelevich R, Meade K, Miller P, Ts’o POP. 1989. Site specificity of the inhibitory effects of oligo(nucleosidemethylphosphonate)s complementary to the acceptor splice junction of herpes simplex virus type 1 immediate early mRNA 4. Proc Natl Acad Sci USA. 86:6868–6872.
   PubMed Web of Science ®Google Scholar
• Lebedeva I, Benimetskaya L, Stein CA, Vilenchik M. 2000. Cellular delivery of antisense oligonucleotides. Eur J Pharm Biopharm. 50:101–119.
   PubMed Web of Science ®Google Scholar
• Liu Q, Cheng S, Li ZB, Xu KT, Chen GQ. 2009. Characterization, biodegradability and blood compatibility of poly[(R)-3-hydroxybutyrate] based poly(ester-urethane)s. J Biomed Mater Res A. 4:1162–1176.
   Web of Science ®Google Scholar
• Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS, Neckers LM. 1989. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA. 86:3474–3478.
   PubMed Web of Science ®Google Scholar
• Matsumono S. 1985. Formulation and stability of water-in-oil-in-water emulsion. ACS symposium series No. 274. American Chemical Society. pp. 415–436.
   Google Scholar
• Necker L, Whitesell L. 1993. Antisense technology: biological utility and practical considerations. Am J Physiol. 265:L1–L12.
   PubMed Web of Science ®Google Scholar
• Sahiner N, Sagbas S, Türk M. 2014. Poly(sucrose) micro particles preparation and their use as biomaterials. Int J Biol Macromol. 66:236–244.
   PubMed Web of Science ®Google Scholar
• Smith CC, Aurelian L, Reddy MP, Miller PS, Ts’o POP. 1986. Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc Natl Acad Sci USA. 83:2787–2791.
   PubMed Web of Science ®Google Scholar
• Song KC, Lee HS, Choung IY, Cho KI, Ahn Y, Choi EJ. 2006. The effect of type of organic phase solvents on the particle size of poly(d,l-lactide-co-glycolide) nanoparticles. Colloids Surf A Physicochem Eng Asp. 276:162–167.
   Web of Science ®Google Scholar
• Tang Y, Li YB, Wang B, Lin RY, Van Dongen M, Zurcher DM, et al. 2012. Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers. Mol Pharm. 9:1812–1821.
   PubMed Web of Science ®Google Scholar
• Yakubov LA, Deeva EA, Zarytova VF, Ivanova EM, Ryte VV, Vlassov SVYL. 1989. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors. Proc Natl Acad Sci USA. 86:6454–6458.
   PubMed Web of Science ®Google Scholar